BioRestorative Therapies (BRTX) Current Leases (2019 - 2024)
BioRestorative Therapies' (BRTX) quarterly Current Leases came in at $42414.0 in Q3 2024, down 72.87% on a YoY basis from $156310.0 in Q4 2023, and down 49.25% quarter-over-quarter from $83580.0 in Q2 2024.
Powered by 
Analysis
BioRestorative Therapies (BRTX) Current Leases (2019 - 2024) Analysis & Trends
BioRestorative Therapies (BRTX) has reported Current Leases for 6 consecutive years, with $42414.0 the latest figure, recorded in Q3 2024.
- For the quarter ending Q3 2024, Current Leases fell 72.87% year-over-year to $42414.0; the trailing twelve-month figure through Sep 2024 stood at $42414.0 (down 72.87% YoY), and the FY2023 full-year result was $162317.0, up 16.5% from the prior year.
- Current Leases retreated to $42414.0 in Q3 2024 per BRTX's latest filing, from $83580.0 in the prior quarter.
- Across five years, Current Leases topped out at $162317.0 in Q4 2023 and bottomed at $42414.0 in Q3 2024.
- Historically, Current Leases has averaged $119796.8 across 5 years, with a median of $123536.0 in 2024.
- The sharpest annual moves came in 2020 and 2024: Current Leases jumped 85.31% in 2020, then sank 72.87% in 2024.
- Over 5 years, Current Leases stood at $158371.0 in 2020, then fell by 24.83% to $119055.0 in 2021, then increased by 17.03% to $139328.0 in 2022, then increased by 16.5% to $162317.0 in 2023, then tumbled by 73.87% to $42414.0 in 2024.
- According to Business Quant data, Current Leases over the past three periods registered $42414.0, $83580.0, and $123536.0 for Q3 2024, Q2 2024, and Q1 2024 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.22 Bn | 9.37 Bn | 112.79 Mn | 1.81 Mn |
| 2 | CRISPR Therapeutics AG | 5.02 Bn | 5.02 Bn | - | 18.65 Mn |
| 3 | Iovance Biotherapeutics | 3.66 Bn | 3.36 Bn | 55.72 Mn | 2.67 Mn |
| 4 | Legend Biotech | 3.54 Bn | 2.58 Bn | 251.50 Mn | - |
| 5 | uniQure | 3.01 Bn | 3.01 Bn | 5.49 Mn | 2.99 Mn |
| 6 | Beam Therapeutics | 2.54 Bn | 2.54 Bn | - | 15.21 Mn |
| 7 | Precigen | 2.38 Bn | 2.38 Bn | 52.17 Mn | 1.06 Mn |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn | - |
| 9 | Vericel | 1.95 Bn | 1.78 Bn | 56.40 Mn | 14.16 Mn |
| 10 | BioRestorative Therapies | 1.25 Mn | -1.71 Mn | 17,964.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 42,414.00 |
| Jun 30, 2024 | 83,580.00 |
| Mar 31, 2024 | 123,536.00 |
| Dec 31, 2023 | 162,317.00 |
| Sep 30, 2023 | 156,310.00 |
| Jun 30, 2023 | 150,480.00 |
| Mar 31, 2023 | 144,821.00 |
| Dec 31, 2022 | 139,328.00 |
| Sep 30, 2022 | 134,031.00 |
| Jun 30, 2022 | 128,899.00 |
| Mar 31, 2022 | 123,899.00 |
| Dec 31, 2021 | 119,055.00 |
| Sep 30, 2021 | 114,387.00 |
| Jun 30, 2021 | 109,856.00 |
| Mar 31, 2021 | 105,459.00 |
| Dec 31, 2020 | 158,371.00 |
| Sep 30, 2020 | 97,081.00 |
| Jun 30, 2020 | 93,093.00 |
| Mar 31, 2020 | 89,222.00 |
| Dec 31, 2019 | 85,465.00 |